Stockreport

How Recent Developments Are Shaping the OptimizeRx Investment Story [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF The consensus analyst price target for OptimizeRx has recently increased from $22 to roughly $24.33 per share. This change is attributed to the company's robust quarterl [Read more]